Perinatal Mental Health Study (PMHS) India
Launched by UNIVERSITY OF OXFORD · Aug 1, 2022
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
The Perinatal Mental Health Study (PMHS) in India is looking to learn more about mental health issues like depression, anxiety, and PTSD in women during and after pregnancy. This study aims to understand how these conditions affect women in India, with the hope of improving support and treatment options for them.
To participate in this study, women aged 18 to 45 who are either currently pregnant, have given birth within the last year, or are not currently pregnant can apply. Participants will need to attend four scheduled visits and provide their consent to take part in the study. It’s important to note that women with severe mental health issues that could prevent them from participating will not be included. Overall, this study is an opportunity for women to share their experiences and contribute to important research that could help others in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- For Phase 1 (qualitative study) and Phase 2 (validation study):
- Pregnant women:
- • Aged 18 to 45 years
- • Currently pregnant (any trimester)
- • Willing and able to give informed consent
- Post-partum women:
- • Aged 18 to 45 years
- • Currently post-partum (between 1-12 months postpartum)
- • Willing and able to give informed consent
- Non-perinatal women:
- • Aged 18 to 45 years
- • Not currently pregnant and not given birth in the past 12 months
- • Willing and able to give informed consent
- For Phase 3 (prospective cohort study):
- Perinatal women:
- • Aged 18 to 45 years
- • In early pregnancy (estimated gestational age \<20 weeks) at recruitment
- • Not planning to relocate for the duration of the study period
- • Willing and able to give informed consent
- • Expressed a willingness to continue to participate for the four planned visits
- Non-perinatal women:
- • Aged 18 to 45 years
- • Not currently pregnant and not given birth in the last 12 months
- • Not planning to relocate for the duration of the study period
- • Willing and able to give informed consent
- • Expressed a willingness to continue to participate for the four planned visits
- Exclusion Criteria:
- The participant may not enter the study if:
- • They have an acutely severe psychiatric illness which impairs their ability to take part in the study
- • They are not willing or able to provide informed consent
- • Other than for current severe psychiatric illness which affects ability to participate in the study, we will not exclude any participant on the basis of current or prior physical, psychological or psychiatric co-morbidities so long as she is willing to participate, her ability to take part is not compromised and her ability to give informed consent is not impaired by these conditions.
About University Of Oxford
The University of Oxford, a prestigious institution renowned for its excellence in research and education, serves as a leading clinical trial sponsor dedicated to advancing medical science and improving patient care. With a rich history of innovation and a multidisciplinary approach, the university leverages its extensive expertise in various fields, including medicine, public health, and biomedical research, to conduct rigorous clinical trials. Collaborating with healthcare professionals, industry partners, and regulatory bodies, the University of Oxford aims to translate groundbreaking research findings into effective therapies and interventions, contributing to the global effort of enhancing health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kangra, Himachal Pradesh, India
Bengaluru, Karnataka, India
Patients applied
Trial Officials
Gracia Fellmeth, DPhil
Principal Investigator
University of Oxford
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials